A fast and simple spectrofluorometric method for the determination of alendronate sodium in pharmaceuticals

BioImpacts

Volumn 4, Issue 1, 2014, Pages 39-42

  Dolatabadi, Jafar Ezzati Nazhad ^a,b   Hamishehkar, Hamed ^c   de la Guardia, Miguel ^d   Valizadeh, Hadi ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Alendronate; Enthalpy; Entropy; O phthalaldehyde; Spectrofluorimetry

Indexed keywords

ALENDRONIC ACID; PHTHALALDEHYDE; SODIUM HYDROXIDE;

ACCURACY; ARTICLE; CALIBRATION; DRUG DETERMINATION; DRUG STRUCTURE; ENTHALPY; ENTROPY; FLUORESCENCE SPECTROSCOPY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; QUANTITATIVE ANALYSIS; SPECTROFLUOROMETRY; TEMPERATURE SENSITIVITY; VALIDATION STUDY;

EID: 84896740924     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2014.005     Document Type: Article

References (16)

1. Sultana S, Talegaonkar S, Ali R, Mittal G, Ahmad FJ, Bhatnagar A. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis. J Microencapsul 2012;29:445-454.
2. Gupta VK, Jain R, Sharma S, Agarwal S, Dwivedi A. Quantitative Determination of Alendronate in Human Urine. Int J Electrochem Sc 2012;7:569-587.
3. Sultana S, Talegaonkar S, Mittal G, Bhatnagar A, Ahmad FJ. Determination of Alendronate Sodium by Box-Behnken Statistical Design. Chromatographia 2010;72:321-326.
4. Su SW, Liao YC, Whang CW. Analysis of alendronate in human urine and plasma by magnetic solid-phase extraction and capillary electrophoresis with fluorescence detection. J Sep Sci 2012;35:681-687.
5. Ban E, Park JY, Kim HT, Kim CK. Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma. Arch Pharm Res 2012;34:2079-2086.
6. Al Deeb SK, Hamdan II, Al Najjar SM. Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine. Talanta 2004;64:695-702.
7. Razak OA, Belal SF, Bedair MM, Haggag RS. The utilization of copper(II) phosphate for the anodic stripping voltammetric assay of alendronate sodium, desferrioxamine mesylate and lisinopril. Talanta 2003;59:1061-1069.
8. Srivastava SK, Gupta VK, Jain S. PVC-Based 2,2,2-Cryptand Sensor for Zinc Ions. Anal Chem 1996;68:1272-1275.
9. Yun MH, Kwon KI. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humans. J Pharmaceut Biomed 2006;40:168-172.
10. Walash MWM, Metwally M, Eid M, El-Shaheny R. Validated spectrophotometric methods for determination of Alendronate sodium in tablets through nucleophilic aromatic substitution reactions. Chem Cent J 2012;6:25.
11. Kashanian S, Ezzati Nazhad Dolatabadi J. In vitro Studies on calf thymus DNA interaction and 2-tert-butyl-4-methylphenol food additive. Eur Food Res Technol 2010;230:821-825.
12. Song G, Yan Q, He Y. Studies on Interaction of Norfloxacin, Cu2+, and DNA by Spectral Methods. J Fluoresc 2005;15:673-678.
13. Kashanian S, Ezzati Nazhad Dolatabadi J. In vitro study of CT-DNA interaction with butylated hydroxyanisole. DNA Cell Biol 2009;28:535-560.
14. Shahabadi N, Kashanian S, Darabi F. In Vitro Study of DNA Interaction with a Water-Soluble Dinitrogen Schiff Base. DNA Cell Biol 2009;28:589-596.
15. Schütz E, von Ahsen N. Influencing factors of dsDNA dye (high-resolution) melting curves and improved genotype call based on thermodynamic considerations. Anal Biochem 2009;385:143-152.
16. Roy S, Banerjee R, Sarkar M. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone. J Inorg Biochem 2006;100:1320-1331.